Chemoinformaics analysis of 1,2-Benzenedicarboxylic acid
| Molecular Weight | 301.298 | nRot | 4 |
| Heavy Atom Molecular Weight | 286.178 | nRig | 14 |
| Exact Molecular Weight | 301.095 | nRing | 2 |
| Solubility: LogS | -3.102 | nHRing | 0 |
| Solubility: LogP | 1.193 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 41.8319 |
| nHD | 3 | BPOL | 17.9501 |
| QED | 0.339 |
| Synth | 2.29 |
| Natural Product Likeliness | -0.007 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.992 |
| HIA | 0.028 |
| CACO-2 | -5.124 |
| MDCK | 0.000105556 |
| BBB | 0.867 |
| PPB | 0.823347 |
| VDSS | 0.978 |
| FU | 0.131281 |
| CYP1A2-inh | 0.681 |
| CYP1A2-sub | 0.117 |
| CYP2c19-inh | 0.276 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.472 |
| CYP2c9-sub | 0.188 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.198 |
| CYP3a4-inh | 0.435 |
| CYP3a4-sub | 0.179 |
| CL | 4.649 |
| T12 | 0.712 |
| hERG | 0.028 |
| Ames | 0.131 |
| ROA | 0.009 |
| SkinSen | 0.066 |
| Carcinogencity | 0.082 |
| EI | 0.068 |
| Respiratory | 0.525 |
| NR-Aromatase | 0.532 |
| Antiviral | Yes |
| Prediction | 0.85685 |